Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.
February 07, 2023 17:48 ET
|
Isoray, Inc.
Company’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies New corporate tagline and website introduced New ticker symbol...
Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders
January 30, 2023 08:10 ET
|
Isoray, Inc.
RICHLAND, Wash., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout...
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023
January 12, 2023 16:05 ET
|
Isoray, Inc.
RICHLAND, Wash., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options...
AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023
December 14, 2022 17:08 ET
|
Isoray, Inc.
RICHLAND, Wash., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout...
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2022
December 14, 2022 16:05 ET
|
Isoray, Inc.
RICHLAND, Wash., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout...
Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger
November 10, 2022 16:05 ET
|
Isoray, Inc.
RICHLAND, Wash., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout...
Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022
October 31, 2022 08:14 ET
|
Isoray, Inc.
RICHLAND, Wash., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout...
Isoray Announces Transformational Merger and Fourth Quarter and Full-Year Fiscal Year End 2022 Financial Results
September 28, 2022 16:05 ET
|
Isoray, Inc.
RICHLAND, Wash., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it has entered into a...
Isoray To Announce Fourth Quarter and Fiscal Year End 2022 Financial Results on September 28, 2022
September 21, 2022 08:13 ET
|
Isoray, Inc.
RICHLAND, Wash., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it will host a...
Isoray’s Cesium-131 Featured in Presentations at American Brachytherapy Society’s Annual Conference
June 21, 2022 08:10 ET
|
Isoray, Inc.
RICHLAND, Wash., June 21, 2022 (GLOBE NEWSWIRE) -- The growing body of information regarding Isoray, Inc.’s (NYSE American: ISR) Cesium-131 in treating prostate cancer was highlighted in two...